StockData
AbbVie Inc. logo

AbbVie Inc. (ABBV) operating KPIs

ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)

Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%

AbbVie short-Term Borrowings ($M) ($M)

Form 10-Q / 10-K Consolidated Balance Sheets

QuarterlyAnnual
Latest, Q2 2026
0
Period ended Jun 30, 2026
Change on a year earlier
-100.0%
5,556 in Q2 2025
History
43 quarters
Since Q1 2015
Sources
36
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedShort-Term Borrowings ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20260-100.0%Form 10-Q (filed 2026-08-03) ↗
Q1 2026Mar 31, 20260-100.0%Form 10-Q (filed 2026-05-08) ↗
Q4 2025Dec 31, 20252,499–Form 10-Q (filed 2026-08-03) ↗
Q3 2025Sep 30, 20253,790–Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 20255,556–Form 10-Q (filed 2025-08-04) ↗
Q1 2025Mar 31, 20251,593+53,000.0%Form 10-Q (filed 2025-05-09) ↗
Q4 2024Dec 31, 20240–Form 10-K (filed 2026-02-20) ↗
Q1 2024Mar 31, 20243+200.0%Form 10-Q (filed 2024-05-03) ↗
Q4 2023Dec 31, 20230-100.0%Form 10-Q (filed 2024-05-03) ↗
Q3 2023Sep 30, 20232-80.0%Form 10-Q (filed 2023-11-06) ↗
Q2 2023Jun 30, 20230-100.0%Form 10-Q (filed 2023-08-07) ↗
Q1 2023Mar 31, 20231-91.7%Form 10-Q (filed 2023-05-05) ↗
Q4 2022Dec 31, 20221-92.9%Form 10-K (filed 2024-02-20) ↗
Q3 2022Sep 30, 202210-37.5%Form 10-Q (filed 2022-11-04) ↗
Q2 2022Jun 30, 2022170.0%Form 10-Q (filed 2022-08-04) ↗
Q1 2022Mar 31, 202212+33.3%Form 10-Q (filed 2022-05-06) ↗

Cite this data

StockData. (2026). AbbVie Short-Term Borrowings ($M) ($M), quarterly Q1 2015–Q2 2026 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/debt_st_borr

See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.